@dhillierwrites I’m at this festival, and it was all getting too much. I went back to my tent and curled up in the fetal position to ride out the storm. I was lying there and heard my tent unzip, so I rolled over to see who it was. It was me coming into the tent.
The Psychedelics as Medicine Report: Fourth Edition is out now.
The industry leading publication provides market insights and intelligence, empowering investors, academics and regulators to make informed decisions.
Download your complimentary copy today:
https://t.co/RVX22JayJc
Small Pharma 's CEO George Tziras has been with the company since its inception, with extensive experience in investment banking.
As @SmallPharma enters the latter stages of clinical trials with its DMT formulation, George shared insights on the roll out of psychedelic medicine.
'With the heritage of psychedelic research, policymakers’ appetite for innovation and a culture of risk-taking among investors...emergence of a psychedelic ecosystem in the UK was inevitable.'
@Clerkenwell_UK maps the domestic landscape and its investors: https://t.co/22vaQg8Tql
'Cannabis companies are joining the market, as are notable leaders from the marijuana space.'
A double death knell for the commercial success of psychedelic healthcare: https://t.co/jy6Oy4lV9D